Effect of open-label infusion of an apoA-I-containing particle (CER-001) on RCT and artery wall thickness in patients with FHA-Reference-Cited by-同舟云学术

Effect of open-label infusion of an apoA-I-containing particle (CER-001) on RCT and artery wall thickness in patients with FHA

Published:2015-03 Issue:3 Volume:56 Page:703-712
ISSN:0022-2275
Container-title:Journal of Lipid Research
language:en
Short-container-title:Journal of Lipid Research

Author:

Kootte Ruud S.,Smits Loek P.,van der Valk Fleur M.,Dasseux Jean-Louis,Keyserling Constance H.,Barbaras Ronald,Paolini John F.,Santos Raul D.,van Dijk Theo H.,Dallinga-van Thie Geesje M.,Nederveen Aart J.,Mulder WillemJ.M.,Hovingh G.Kees,Kastelein JohnJ.P.,Groen Albert K.,Stroes ErikS.

Publisher

Elsevier BV

Subject

Cell Biology,Endocrinology,Biochemistry

Reference49 articles.

1. Residual macrovascular risk in 2013: what have we learned?;Fruchart;Cardiovasc. Diabetol.,2014

2. Emerging Risk Factors Collaboration;Di Angelantonio;Major lipids, apolipoproteins, and risk of vascular disease.JAMA.,2009

3. Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study;Kannel;Ann. Intern. Med.,1979

4. Effects of dalcetrapib in patients with a recent acute coronary syndrome;Schwartz;N. Engl. J. Med.,2012

5. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy;Boden;N. Engl. J. Med.,2011

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New perspectives on the high-density lipoprotein system and its role in the prevention and treatment of atherosclerotic cardiovascular disease;Current Opinion in Endocrinology, Diabetes & Obesity;2024-08-05

2. Reconstituted HDL ameliorated renal injury of diabetic kidney disease in mice;Physiological Reports;2024-08

3. High-density lipoprotein infusion therapy: A review;Journal of Clinical Lipidology;2024-05

4. A Current Update on the Role of HDL-Based Nanomedicine in Targeting Macrophages in Cardiovascular Disease;Pharmaceutics;2023-05-15

5. Beneficial effects of high-density lipoprotein (HDL) on stent biocompatibility and the potential value of HDL infusion therapy following percutaneous coronary intervention;Medicine;2022-11-11